BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  DBV Technologies Reports Full Year 2025 Financial Results and Business Update

  March 27, 2026

   · 

  10 min read
• Press Releases

  Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria

  March 27, 2026

   · 

  6 min read
• Press Releases

  DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document

  March 27, 2026

   · 

  2 min read
• Press Releases

  Onco360® Has Been Selected as the National Pharmacy Partner for LIFYORLI™ (relacorilant)

  March 27, 2026

   · 

  2 min read
• Press Releases

  Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update

  March 27, 2026

   · 

  23 min read
• Press Releases

  Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

  March 27, 2026

   · 

  11 min read
• Press Releases

  Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity

  March 27, 2026

   · 

  11 min read
• Press Releases

  Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock

  March 27, 2026

   · 

  11 min read
• Press Releases

  CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results

  March 27, 2026

   · 

  10 min read
• Press Releases

  Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million

  March 27, 2026

   · 

  3 min read